Quest Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2 hours ago
share
Share Via
At Rs 110.25, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Quest Laboratories Ltd locked at its upper circuit of 5% on 13 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Quest Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock, trading in the ST series, hit its maximum allowed daily gain of 5%, moving from a low of Rs 106.65 to a high of Rs 110.25. This 5% price band capped the session’s upside, effectively freezing trading at the ceiling price. The upper circuit mechanism means that while there were buyers willing to purchase shares at Rs 110.25, no sellers were prepared to sell at that level, creating a scenario of unfilled demand. This dynamic often signals strong buying interest but also limits liquidity, especially in micro-cap stocks like Quest Laboratories Ltd.

Delivery and Volume Analysis

Volume on circuit days is typically suppressed due to the price lock, and Quest Laboratories Ltd was no exception, with total traded volume at just 0.108 lakh shares and turnover of Rs 0.1177 crore. However, the delivery volume tells a more compelling story. On 10 Apr 2026, delivery volume rose by 36.36% compared to the 5-day average, reaching 10,800 shares. This increase in delivery volume suggests that the shares traded were not merely speculative intraday trades but were being taken into investors’ portfolios for the longer term. Rising delivery volumes during an upper circuit day are a strong signal of conviction buying rather than fleeting momentum — is this surge backed by genuine investor interest or just a short-term spike?

Moving Averages and Trend Context

Technically, Quest Laboratories Ltd is positioned above its 5-day, 20-day, 100-day, and 200-day moving averages, indicating a generally bullish trend. However, it remains below its 50-day moving average, which may act as a resistance level in the near term. The stock’s ability to hit the upper circuit while already above most key moving averages suggests that the rally is supported by a positive trend structure. The narrow intraday range from Rs 106.65 to Rs 110.25, culminating in the circuit lock, reflects a steady upward momentum rather than volatile swings — does this technical setup signal a sustainable breakout or a temporary spike?

Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!

  • - Complete fundamentals package
  • - Technical momentum confirmed
  • - Reasonable valuation entry

Add to Your Radar Now →

Liquidity and Market Capitalisation Context

With a market capitalisation of Rs 181 crore, Quest Laboratories Ltd is classified as a micro-cap stock. This segment is characterised by thinner liquidity and more pronounced price swings, making upper circuit hits more frequent and impactful. The stock’s liquidity profile, based on 2% of the 5-day average traded value, indicates it is liquid enough for a trade size of Rs 0 crore, effectively signalling very limited institutional-grade liquidity. This thin order book means that while the upper circuit reflects strong buying interest, the ability to enter or exit sizeable positions without impacting the price remains constrained. Investors should be mindful of this liquidity risk when analysing the circuit event — how does this liquidity limitation affect the stock’s risk profile?

Intraday Price Action

The intraday price range was relatively narrow, with the stock moving between Rs 106.65 and Rs 110.25 before locking at the upper circuit. This pattern is typical for circuit-bound stocks, where the price gravitates steadily towards the ceiling and then remains fixed due to the absence of sellers. The lack of significant intraday volatility suggests that the buying pressure was consistent throughout the session rather than concentrated in a short burst. This steady climb to the circuit price reinforces the notion of sustained demand rather than speculative spikes.

Brief Fundamental Context

Quest Laboratories Ltd operates in the Pharmaceuticals & Biotechnology sector, a space that often attracts investor attention due to its growth potential and defensive characteristics. While the company’s micro-cap status means it is more susceptible to liquidity-driven price moves, its position above key moving averages and rising delivery volumes suggest that the recent price action is not purely speculative. However, the absence of detailed fundamental data in this report limits a deeper assessment of valuation or earnings trends.

Holding Quest Laboratories Ltd from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at Rs 110.25 capped a 5% gain for Quest Laboratories Ltd, reflecting strong buying interest that exceeded the price band’s allowance. The 36.36% rise in delivery volume against the 5-day average indicates that the shares traded were largely taken into long-term portfolios rather than being flipped intraday, lending credibility to the move. The stock’s position above most moving averages further supports a bullish trend context. However, the micro-cap status and limited liquidity, with a trade size capacity of effectively zero crore rupees, highlight the risks associated with thin order books and potential price volatility when attempting to transact larger volumes. The circuit locked in gains but also locked out buyers who arrived late — is Quest Laboratories Ltd’s 5% surge a sign of sustainable momentum or a liquidity-driven micro-cap phenomenon?

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Quest Laboratories Ltd is Rated Buy by MarketsMOJO
Apr 05 2026 10:10 AM IST
share
Share Via
Quest Laboratories Ltd is Rated Buy by MarketsMOJO
Mar 24 2026 10:10 AM IST
share
Share Via
Quest Laboratories Ltd is Rated Strong Buy
Mar 13 2026 10:10 AM IST
share
Share Via
Quest Laboratories Ltd is Rated Strong Buy
Mar 02 2026 10:10 AM IST
share
Share Via